====================================================================================================
                       GO DISEASE ANALYZER - PROVENANCE VISUALIZATION
====================================================================================================

┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                                              QUERY                                               │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│  GO Term:  GO:0042113 (B cell activation)                                                        │
│  Disease:  systemic lupus erythematosus                                                          │
│  Tissue:   blood                                                                                 │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘
                                             │
                                             ▼
┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                                LAYER 1: KNOWLEDGE GRAPH DISCOVERY                                │
│                                      (Ubergraph + Wikidata)                                      │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│                                                                                                  │
│  ┌───────────────────────────────────────┐    ┌───────────────────────────────────────┐  │
│  │           UBERGRAPH                   │    │              WIKIDATA                 │  │
│  │        (GO Ontology)                  │    │         (Gene Annotations)           │  │
│  ├───────────────────────────────────────┤    ├───────────────────────────────────────┤  │
│  │  GO:0042113                         │───►│  Query: genes annotated to            │  │
│  │  + subclass terms                    │    │  these GO terms in humans            │  │
│  └───────────────────────────────────────┘    └───────────────────────────────────────┘  │
│                                                                                                  │
│  RESULT: 30 genes discovered                                                                     │
│                                                                                                  │
│  Gene → GO term mappings:                                                                        │
│  ┌────────────┬───────────────────────────────────────────────────────────────────────┐  │
│  │   Gene     │  GO Terms                                                             │  │
│  ├────────────┼───────────────────────────────────────────────────────────────────────┤  │
│  │ PTK2B      │ marginal zone B cell differentiation                              │  │
│  │ CD19       │ B cell proliferation involved in immune response, B-1 B cell d... │  │
│  │ KIT        │ immature B cell differentiation, B cell differentiation           │  │
│  │ CD180      │ B cell proliferation involved in immune response                  │  │
│  │ ABL1       │ B cell proliferation involved in immune response, B cell proli... │  │
│  └────────────┴───────────────────────────────────────────────────────────────────────┘  │
│                                                                                                  │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘
                                             │
                    Genes: PTK2B, CD19, KIT, CD180, ABL1, TLR4, ...
                                             │
                                             ▼
┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                             LAYER 2: SINGLE-CELL EXPRESSION ANALYSIS                             │
│                                        (CellxGene Census)                                        │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│                                                                                                  │
│  ┌────────────────────────────────────────────┐  ┌────────────────────────────────────┐  │
│  │  NORMAL BLOOD                            │  │  SYSTEMIC LUPUS ERYTHEMATOSUS    │  │
│  │  (control cells)                           │  │  (disease cells)                   │  │
│  └────────────────────────────────────────────┘  └────────────────────────────────────┘  │
│                             │                           │                                │
│                             └───────────┬───────────────┘                                │
│                                         ▼                                                │
│                             Compare expression per cell type                             │
│                                                                                                  │
│  ┌──────────────────────────────────────────────────────────────────────────────────────────┐  │
│  │  TISSUE-LEVEL SUMMARY (blood, normal vs systemic lupus erythematosus)                      │  │
│  ├──────────────────────────────────────────────────────────────────────────────────────────┤  │
│  │  9 of 30 genes UPREGULATED (max FC > 1.5 in at least one cell type)                        │  │
│  │  1 of 30 genes DOWNREGULATED (max FC < 0.67 across all cell types)                         │  │
│  │                                                                                            │  │
│  │  (A gene is 'upregulated' if ANY cell type shows FC > 1.5)                                 │  │
│  │  (A gene is 'downregulated' only if ALL cell types show FC < 0.67)                         │  │
│  └──────────────────────────────────────────────────────────────────────────────────────────┘  │
│                                                                                                  │
│  Top Upregulated Genes (ranked by max fold change across cell types):                            │
│  ┌────────────┬────────────┬─────────────────────────────────────────────────────────┐  │
│  │   Gene     │ Fold Change│  Top Cell Type                                          │  │
│  ├────────────┼────────────┼─────────────────────────────────────────────────────────┤  │
│  │ ICOSLG     │       3.17 │ lymphocyte                                              │  │
│  │ CD19       │       3.00 │ lymphocyte                                              │  │
│  │ FCGR2B     │       3.00 │ lymphocyte                                              │  │
│  │ IRF2BP2    │       2.73 │ lymphocyte                                              │  │
│  │ BAX        │       2.19 │ lymphocyte                                              │  │
│  └────────────┴────────────┴─────────────────────────────────────────────────────────┘  │
│                                                                                                  │
│  ┌──────────────────────────────────────────────────────────────────────────────────────────┐  │
│  │  CELL-TYPE LEVEL BREAKDOWN (drilling down within the tissue)                               │  │
│  ├──────────────────────────────────────────────────────────────────────────────────────────┤  │
│  │  Shows expression changes within each specific cell population.                            │  │
│  │  Note: The SAME gene can be UP in one cell type and DOWN in another!                       │  │
│  │  (e.g., CD19 is UP 3x in lymphocytes but DOWN in NK cells and monocytes)                   │  │
│  └──────────────────────────────────────────────────────────────────────────────────────────┘  │
│  ┌─────────────────────────────────┬─────┬─────┬───────────────────────────────────┐  │
│  │  Cell Type                      │  ↑  │  ↓  │  Genes changed in this cell type  │  │
│  ├─────────────────────────────────┼─────┼─────┼───────────────────────────────────┤  │
│  │ lymphocyte                      │   9 │   1 │ CD19, BAX, PLCL2, IRF2BP2, ICOSLG │  │
│  │ natural killer cell             │   0 │  16 │ PTK2B, CD19, ABL1, PLCL2, FNIP1   │  │
│  │ CD4-positive, alpha-beta T ...  │   0 │  15 │ PTK2B, ABL1, PLCL2, FNIP1, IRF... │  │
│  │ classical monocyte              │   0 │  19 │ PTK2B, CD180, ABL1, TLR4, PLCL2   │  │
│  │ B cell                          │   0 │  19 │ PTK2B, CD19, CD180, ABL1, PLCL2   │  │
│  └─────────────────────────────────┴─────┴─────┴───────────────────────────────────┘  │
│                                                                                                  │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘
                                             │
                    ┌─────────────────────────────────────────────────────────┐
                    │ GENES PASSED TO LAYER 3: 9 upregulated genes from above│
                    │ (ranked by max fold change at tissue level)            │
                    │ → ICOSLG, CD19, FCGR2B, IRF2BP2, BAX...               │
                    └─────────────────────────────────────────────────────────┘
                                             │
                                             ▼
┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                                 LAYER 3: BULK RNA-SEQ VALIDATION                                 │
│                                          (ARCHS4 / GEO)                                          │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│                                                                                                  │
│  ┌──────────────────────────────────────────────────────────────────────────────────────────┐  │
│  │  VALIDATION HYPOTHESIS:                                                                  │  │
│  │  Do the genes upregulated in single-cell (Layer 2) also show upregulation in             │  │
│  │  independent bulk RNA-seq studies from GEO?                                              │  │
│  │                                                                                          │  │
│  │  Test: Compare expression in 'systemic lupus erythematosus' samples                        │  │
│  │        vs 'normal blood' samples from ARCHS4                                               │  │
│  └──────────────────────────────────────────────────────────────────────────────────────────┘  │
│                                                                                                  │
│  ┌──────────────────────────────────────────────────────────────────────────────────────────┐  │
│  │  ARCHS4 DATA AVAILABILITY:                                                              │  │
│  ├──────────────────────────────────────────────────────────────────────────────────────────┤  │
│  │  Studies:  10 with expression data (examined 10 of 22 in metadata)                         │  │
│  │  Disease:  369 samples with data (of 523 in metadata)                                      │  │
│  │  Control:  23 samples with data (of 23 in metadata)                                        │  │
│  └──────────────────────────────────────────────────────────────────────────────────────────┘  │
│                                                                                                  │
│  ╔═══════════════════════════════════════════════════════════════════════════════════════════╗  │
│  ║  DISEASE STUDIES                                                                          ║  │
│  ╠═══════════════════════════════════════════════════════════════════════════════════════════╣  │
│  ║  GSE72420: SLE1                                                                           ║  │
│  ║    Samples: 98  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM1863633: SLE1                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_high                                 ║  │
│  ║      • GSM1863634: SLE2                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_high                                 ║  │
│  ║      • GSM1863635: SLE3                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_high                                 ║  │
│  ║      • GSM1863636: SLE4                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_low                                  ║  │
│  ║      • GSM1863637: SLE5                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, med anti-Ro, ISM_low                                   ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE72509: SLE1                                                                           ║  │
│  ║    Samples: 98  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM1863633: SLE1                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_high                                 ║  │
│  ║      • GSM1863634: SLE2                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_high                                 ║  │
│  ║      • GSM1863635: SLE3                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_high                                 ║  │
│  ║      • GSM1863636: SLE4                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, high anti-Ro, ISM_low                                  ║  │
│  ║      • GSM1863637: SLE5                                                                   ║  │
│  ║        Source: PAXgene blood, SLE, med anti-Ro, ISM_low                                   ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE80183: S02 Anti-dsDNA+ SLE patient                                                    ║  │
│  ║    Samples: 12  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM2114345: S02 Anti-dsDNA+ SLE patient                                            ║  │
│  ║        Source: Blood                                                                      ║  │
│  ║      • GSM2114346: S03 Anti-dsDNA+ SLE patient                                            ║  │
│  ║        Source: Blood                                                                      ║  │
│  ║      • GSM2114347: S06 Anti-dsDNA+ SLE patient                                            ║  │
│  ║        Source: Blood                                                                      ║  │
│  ║      • GSM2114348: S09 Anti-dsDNA+ SLE patient                                            ║  │
│  ║        Source: Blood                                                                      ║  │
│  ║      • GSM2114349: S12 Anti-dsDNA+ENA+ SLE patient                                        ║  │
│  ║        Source: Blood                                                                      ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE92387: Sample_01_SLE4079_NAV                                                          ║  │
│  ║    Samples: 12  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM2428862: Sample_01_SLE4079_NAV                                                  ║  │
│  ║        Source: peripheral blood mononuclear cells                                         ║  │
│  ║      • GSM2428863: Sample_02_SLE4079_SWM                                                  ║  │
│  ║        Source: peripheral blood mononuclear cells                                         ║  │
│  ║      • GSM2428864: Sample_03_SLE4079_DN1                                                  ║  │
│  ║        Source: peripheral blood mononuclear cells                                         ║  │
│  ║      • GSM2428865: Sample_04_SLE4079_DN2                                                  ║  │
│  ║        Source: peripheral blood mononuclear cells                                         ║  │
│  ║      • GSM2428866: Sample_05_SLE2581_NAV                                                  ║  │
│  ║        Source: peripheral blood mononuclear cells                                         ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE92472: Systemic lupus erythematosus                                                   ║  │
│  ║    Samples: 1  |  Genes detected: 9                                                       ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM2430383: Systemic lupus erythematosus                                           ║  │
│  ║        Source: peripheral whole blood draw                                                ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE109843: SLE111-PD1POS                                                                 ║  │
│  ║    Samples: 20  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM2971177: SLE111-PD1POS                                                          ║  │
│  ║        Source: whole blood                                                                ║  │
│  ║      • GSM2971178: SLE111-Tfh                                                             ║  │
│  ║        Source: whole blood                                                                ║  │
│  ║      • GSM2971179: SLE224-PD1POS                                                          ║  │
│  ║        Source: whole blood                                                                ║  │
│  ║      • GSM2971180: SLE224-Tfh                                                             ║  │
│  ║        Source: whole blood                                                                ║  │
│  ║      • GSM2971181: SLE267-PD1POS                                                          ║  │
│  ║        Source: whole blood                                                                ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE110999: RMS28901-2                                                                    ║  │
│  ║    Samples: 11  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM3019882: RMS28901-2                                                             ║  │
│  ║        Source: CD19+CD11chi IgD- B cells                                                  ║  │
│  ║      • GSM3019883: RMS28901-3                                                             ║  │
│  ║        Source: CD19+ CD11c- CD27+ IgD- Memory B cells                                     ║  │
│  ║      • GSM3019884: RMS28901-4                                                             ║  │
│  ║        Source: CD19+ CD11c- CD27- IgD+ NaÃ¯ve B cells                                     ║  │
│  ║      • GSM3019885: RMS28901-5                                                             ║  │
│  ║        Source: CD19+CD11chi IgD+ B cells                                                  ║  │
│  ║      • GSM3019886: RMS28901-6                                                             ║  │
│  ║        Source: CD19+CD11chi IgD- B cells                                                  ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE116193: lgs101293_RNA-seq                                                             ║  │
│  ║    Samples: 25  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM3212894: lgs101293_RNA-seq                                                      ║  │
│  ║        Source: RNA-seq                                                                    ║  │
│  ║      • GSM3212895: lgs301283_RNA-seq                                                      ║  │
│  ║        Source: RNA-seq                                                                    ║  │
│  ║      • GSM3212896: lgs301430_RNA-seq                                                      ║  │
│  ║        Source: RNA-seq                                                                    ║  │
│  ║      • GSM3212897: lgs304050_RNA-seq                                                      ║  │
│  ║        Source: RNA-seq                                                                    ║  │
│  ║      • GSM3212898: lgs302634_RNA-seq                                                      ║  │
│  ║        Source: RNA-seq                                                                    ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE118254: SLE.223.aN [RNA-seq]                                                          ║  │
│  ║    Samples: 46  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM3323667: SLE.223.aN [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323668: SLE.223.DN [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323669: SLE.223.PbPc [RNA-seq]                                                 ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323670: SLE.223.rN [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323671: SLE.223.SM [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ║  GSE118256: SLE.223.aN [RNA-seq]                                                          ║  │
│  ║    Samples: 46  |  Genes detected: 9                                                      ║  │
│  ║    Sample Details:                                                                        ║  │
│  ║      • GSM3323667: SLE.223.aN [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323668: SLE.223.DN [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323669: SLE.223.PbPc [RNA-seq]                                                 ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323670: SLE.223.rN [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║      • GSM3323671: SLE.223.SM [RNA-seq]                                                   ║  │
│  ║        Source: SLE_Circulating B cells                                                    ║  │
│  ║    Genes: ICOSLG, CD19, FCGR2B, IRF2BP2, BAX, HSPD1, PLCL2, PLCG2, ATP11C                 ║  │
│  ╚═══════════════════════════════════════════════════════════════════════════════════════════╝  │
│                                                                                                  │
│  ╔═══════════════════════════════════════════════════════════════════════════════════════════╗  │
│  ║  CONTROL SAMPLES                                                                          ║  │
│  ╠═══════════════════════════════════════════════════════════════════════════════════════════╣  │
│  ║  • GSM2885044 (GSE107981): hu_Tn.1                                                        ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885045 (GSE107981): hu_Tn.2                                                        ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885046 (GSE107981): hu_Tn.3                                                        ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885047 (GSE107981): hu_Tn.4                                                        ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885048 (GSE107981): hu_Th1.1                                                       ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885049 (GSE107981): hu_Th1.2                                                       ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885050 (GSE107981): hu_Th1.3                                                       ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM2885051 (GSE107981): hu_Th1.4                                                       ║  │
│  ║    Source: peripheral blood mononuclear cell                                              ║  │
│  ║  • GSM3377676 (GSE119562): human blood NK cells from donor 1                              ║  │
│  ║    Source: Normal blood human NK cells                                                    ║  │
│  ║  • GSM3377677 (GSE119562): human blood NK cells from donor 2                              ║  │
│  ║    Source: Normal blood human NK cells                                                    ║  │
│  ╚═══════════════════════════════════════════════════════════════════════════════════════════╝  │
│                                                                                                  │
│  Differential Expression (Disease vs Controls):                                                  │
│  ┌────────────┬────────────┬────────────┬────────────┬──────────┬─────────────────────────┐  │
│  │   Gene     │  Disease   │  Control   │ Fold Change│ Log2 FC  │    Interpretation       │  │
│  ├────────────┼────────────┼────────────┼────────────┼──────────┼─────────────────────────┤  │
│  │ CD19       │     5960.2 │       34.9 │     166.19 │     7.38 │ STRONGLY UP             │  │
│  │ FCGR2B     │     4165.1 │      193.0 │      21.47 │     4.42 │ STRONGLY UP             │  │
│  │ PLCG2      │    10044.1 │      785.8 │      12.77 │     3.67 │ STRONGLY UP             │  │
│  │ ICOSLG     │     3009.7 │      812.3 │       3.70 │     1.89 │ STRONGLY UP             │  │
│  │ IRF2BP2    │     6042.4 │     4762.0 │       1.27 │     0.34 │ UNCHANGED               │  │
│  │ PLCL2      │     1689.3 │     1333.7 │       1.27 │     0.34 │ UNCHANGED               │  │
│  │ ATP11C     │     1167.6 │      970.1 │       1.20 │     0.27 │ UNCHANGED               │  │
│  │ BAX        │     2651.6 │     2586.3 │       1.03 │     0.04 │ UNCHANGED               │  │
│  │ HSPD1      │     7729.0 │    10827.0 │       0.71 │    -0.49 │ UNCHANGED               │  │
│  └────────────┴────────────┴────────────┴────────────┴──────────┴─────────────────────────┘  │
│                                                                                                  │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘
                                             │
                                             ▼
┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                                 LAYER 4: INTEGRATED CONCLUSIONS                                  │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│                                                                                                  │
│  KEY FINDINGS:                                                                                   │
│                                                                                                  │
│  1. CD19 shows 166.2x expression in systemic lupus erythematosus                                 │
│  2. lymphocyte is the primary driver (9 genes upregulated)                                       │
│  3. 4 of 9 top genes validated in bulk RNA-seq (GEO)                                             │
│  4. Most strongly validated: CD19, FCGR2B, PLCG2                                                 │
│                                                                                                  │
│  DATA PROVENANCE:                                                                                │
│    • GO terms: Ubergraph (subclasses of GO:0042113)                                              │
│    • Gene annotations: Wikidata (human protein → GO term links)                                  │
│    • Single-cell: CellxGene Census (blood, normal vs systemic lupus erythematosus)               │
│    • Bulk validation: ARCHS4/GEO (GSE72420, GSE72509, GSE80183, GSE92387, GSE92472, GSE109843, GSE110999, GSE116193, GSE118254, GSE118256)│
│      Disease samples: GSM1863633, GSM1863634, GSM1863635, GSM1863636, GSM1863637, GSM1863...     │
│      Control samples: GSM2885044, GSM2885045, GSM2885046, GSM2885047, GSM2885048, GSM2885...     │
│                                                                                                  │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘

┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                                      LLM-GENERATED SUMMARY                                       │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│                                                                                                  │
│  Multi-Layer Gene Expression Analysis: B Cell Activation Genes in Systemic Lupus Erythematosus   │
│  ------------------------------------------------------------                                   │
│                                                                                                  │
│  This comprehensive analysis identified 30 genes involved in B cell activation (GO:0042113)      │
│  and examined their dysregulation in systemic lupus erythematosus (SLE) using a three-layer      │
│  approach combining knowledge graphs, single-cell RNA-seq, and bulk validation data. At the      │
│  tissue level in blood, 9 genes showed upregulation with fold changes >1.5, led by ICOSLG        │
│  (3.17-fold), CD19 (3.0-fold), and FCGR2B (3.0-fold). However, this tissue-level summary         │
│  masks striking cell-type-specific differences, where the same genes can show opposite           │
│  regulatory patterns across different immune cell populations.                                   │
│                                                                                                  │
│  The cell-type analysis revealed that **lymphocytes are the primary drivers of B cell            │
│  activation gene upregulation in SLE**, with 9 upregulated and only 1 downregulated gene. Key    │
│  upregulated genes in lymphocytes include the B cell marker CD19, the apoptosis regulator        │
│  BAX, phospholipase signaling components (PLCL2, PLCG2), the co-stimulatory molecule ICOSLG,     │
│  and the inhibitory Fc receptor FCGR2B. In stark contrast, all other major immune cell types     │
│  showed predominantly downregulation of these same genes: natural killer cells (0 up, 16         │
│  down), CD4+ T cells (0 up, 15 down), classical monocytes (0 up, 19 down), and even B cells      │
│  themselves (0 up, 19 down). This paradoxical pattern suggests that the "lymphocyte"             │
│  population driving upregulation may represent activated or pathogenic B cell subsets not        │
│  captured in the broader "B cell" category.                                                      │
│                                                                                                  │
│  Bulk RNA-seq validation across 10 independent studies (GSE72420, GSE72509, GSE80183,            │
│  GSE92387, GSE92472, and others) strongly confirmed the single-cell findings, with CD19          │
│  showing the most dramatic upregulation (166-fold, log2FC=7.38), followed by FCGR2B (21-fold,    │
│  log2FC=4.42) and PLCG2 (13-fold, log2FC=3.67). The validation extends beyond the top hits,      │
│  with ICOSLG showing 3.7-fold upregulation and more modest but consistent increases in           │
│  IRF2BP2, PLCL2, and ATP11C. Only HSPD1 showed downregulation in bulk samples, aligning with     │
│  its mixed single-cell patterns.                                                                 │
│                                                                                                  │
│  These findings suggest that SLE involves aberrant activation of specific B cell                 │
│  subpopulations that highly express canonical B cell activation machinery, while other immune    │
│  cells show compensatory downregulation. The robust validation across multiple GEO datasets      │
│  strengthens confidence in CD19, FCGR2B, and PLCG2 as key dysregulated B cell activation         │
│  genes in SLE, potentially representing therapeutic targets or biomarkers for monitoring         │
│  disease activity in this complex autoimmune disorder.                                           │
│                                                                                                  │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘

====================================================================================================
  Analysis timestamp: 2025-12-09T17:59:54.730244+00:00
====================================================================================================